503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
23.59%
Revenue growth 1.25-1.5x BB's 20.94%. Bruce Berkowitz would examine if growth advantage is sustainable.
58.38%
Cost growth above 1.5x BB's 19.52%. Michael Burry would check for structural cost disadvantages.
15.95%
Gross profit growth 50-75% of BB's 22.64%. Martin Whitman would scrutinize competitive position.
-6.19%
Margin decline while BB shows 1.40% expansion. Joel Greenblatt would examine competitive position.
84.42%
R&D growth above 1.5x BB's 2.72%. Michael Burry would check for spending discipline.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
76.58%
Operating expenses growth above 1.5x BB's 0.31%. Michael Burry would check for inefficiency.
71.27%
Total costs growth above 1.5x BB's 9.78%. Michael Burry would check for inefficiency.
No Data
No Data available this quarter, please select a different quarter.
-8.54%
Both companies reducing D&A. Martin Whitman would check industry patterns.
-57.57%
EBITDA decline while BB shows 5610.96% growth. Joel Greenblatt would examine position.
-72.17%
EBITDA margin decline while BB shows 98.73% growth. Joel Greenblatt would examine position.
-53.14%
Operating income decline while BB shows 99.31% growth. Joel Greenblatt would examine position.
-62.09%
Operating margin decline while BB shows 99.43% growth. Joel Greenblatt would examine position.
11.16%
Other expenses growth while BB reduces costs. John Neff would investigate differences.
-40.73%
Pre-tax income decline while BB shows 126.39% growth. Joel Greenblatt would examine position.
-52.05%
Pre-tax margin decline while BB shows 121.82% growth. Joel Greenblatt would examine position.
-40.71%
Tax expense reduction while BB shows 146.30% growth. Joel Greenblatt would examine advantage.
-40.74%
Net income decline while BB shows 126.39% growth. Joel Greenblatt would examine position.
-52.05%
Net margin decline while BB shows 121.82% growth. Joel Greenblatt would examine position.
-41.67%
EPS decline while BB shows 128.41% growth. Joel Greenblatt would examine position.
-41.67%
Diluted EPS decline while BB shows 128.41% growth. Joel Greenblatt would examine position.
-0.01%
Share count reduction while BB shows 0.50% change. Joel Greenblatt would examine strategy.
0.13%
Diluted share reduction exceeding 1.5x BB's 5.63%. David Dodd would verify capital allocation.